Please read and agree to the
terms and conditions
of this site.
I agree
Funding Series
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
clinical trials
3
×
funding
life sciences
national blog main
venture capital
cancer
financing
orbimed
seattle blog main
abbvie
acerta pharma
adage capital management
adverse events
alexandria venture investments
antibody drugs
antibody-drug conjugate
arix
arix bioscience
astrazeneca
bispecific antibodies
bristol meyers squibb
calistoga pharmaceuticals
celgene
citadel
clayton knox
colt ventures
cormorant asset management
dallas
dave johnson
decheng capital
drug conjugates
exobyte
farallon
foresite capital
funds and accounts advised by t. rowe price associates
gilead sciences
her2
her2 positive
hif-2a
What
cancer
3
×
drug
3
×
drugs
targeting
therapeutics
years
adds
advance
antibody
avoid
based
biotech
ceo
clinical
dallas
dangerous
dave
developer
developing
diego
diseases
effects
filed
immunotherapies
initial
ipo
johnson
kept
kidney
kipps
known
molecule
nearly
offering
peloton
physician
plans
public
reseacher
ror
Language
unset
Current search:
drug
×
biotech
×
" clinical trials "
×
cancer
×
{{ ::tile.facetWhoCard }}
{{ ::tile.pubDate | moment: 'fromNow'}}
Paste
[[item:{{::tile.id}}]]
to render this photo inside an other item's description.
PROCESSING
TRANSCODING
ERROR
EXTRACTING
ERROR
{{::tile.title}}